EU MDR 2017/745 Compliance Consultants Texas

Reaching the European market opens real growth for Texas medical device companies. To get there, your device must meet EU MDR 2017/745. MedLaunch helps you meet that standard with clear, step-by-step guidance built for your product and timeline.

What Is EU MDR 2017/745?

EU MDR 2017/745 is the European Union’s Medical Device Regulation. It sets the rules for how medical devices reach and stay on the European market. The regulation raises the bar on device safety, clinical evidence, and accountability across the full product lifecycle.

For Texas companies, this matters the moment you target European sales. Strong compliance protects patients, supports your brand, and keeps your path to market on schedule. Weak compliance can stall approvals, delay launches, and increase costs.

Common Pain Points We Help You Solve

Texas teams often hit the same hurdles during EU MDR work. Here is where we focus.

Technical Documentation

Your technical documentation is the foundation of EU MDR compliance. It must show that your device is safe and performs as intended. We help you prepare and review the full file, including device descriptions, risk assessments, and quality records, so it holds up under review.

Clinical Evaluation Reports (CER)

The EU MDR places strong weight on clinical evidence. Your Clinical Evaluation Report must show your device’s safety and performance through sound data. We help you structure your CER, identify evidence gaps, and present a clear, defensible case.

post-market surveillance (PMS)

Compliance does not end at approval. The EU MDR requires active post-market surveillance to track device performance over time. We help you build PMS systems that collect data, flag issues early, and support fast, documented responses.

Why EU MDR Compliance Cannot Wait

The EU MDR is now in force, and enforcement is active. Devices that fall short face real consequences:

• Delayed or denied European market access
• Loss of certification for products already on the market
• Higher remediation costs and lost revenue
• Setbacks to funding, partnerships, and growth

For startups and mid-size companies on tight timelines, these setbacks hit hard. Early, structured compliance keeps your launch on track.

How MedLaunch Helps Texas Companies Reach Europe

We bridge the gap between local innovation and European compliance with hands-on support:

• Gap Analysis and Strategy: We compare your current system against EU MDR requirements and build a clear plan to close the gaps.
• Technical Documentation Support: We prepare and review the documentation that anchors your compliance.
• Post-Market Surveillance Setup: We help you implement surveillance systems that keep you compliant after launch.
• EU MDR Training: We equip your team with the knowledge to maintain compliance long term.

Frequently Asked Questions

What is EU MDR 2017/745?

It is the European Union’s Medical Device Regulation. It governs how medical devices are approved, marketed, and monitored across the EU.

Does EU MDR apply to Texas companies?

Yes. Any company that sells medical devices in the European market must meet EU MDR requirements, regardless of where it is based.

What happens if my device is not compliant?

You risk delayed or denied market access, loss of certification, and added cost from rework.

When should I start EU MDR work?

Start early. Building documentation, clinical evidence, and surveillance systems takes time, and early planning reduces risk.

Schedule a Consultation With MedLaunch

Your device deserves a clear path to the European market. Contact MedLaunch to schedule a consultation, and let our team guide your EU MDR 2017/745 compliance from gap analysis through launch.